Opening book details…
About this Medicine article
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial by Miller, P.D.; Hattersley, G.; Lau, E.; Fitzpatrick, L.A.; Harris, A.G.; Williams, G.C.; Hu, M.-Y.; Riis, B.J.; Russo, L.; Christiansen, C. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Miller, P.D.; Hattersley, G.; Lau, E.; Fitzpatrick, L.A.; Harris, A.G.; Williams, G.C.; Hu, M.-Y.; Riis, B.J.; Russo, L.; Christiansen, C.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 8756-3282)
- Published
- 2019
- Language
- EN
- Field
- Medicine (Health Sciences)